The DOI matches its Crossref record; 90 of the 92 references it cites were found in a registry or an index.
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Open accessAbstract
Non-alcoholic fatty liver disease ranges from steatosis to non-alcoholic steatohepatitis (NASH), potentially progressing to cirrhosis and hepatocellular carcinoma (HCC). Here, we show that platelet number, platelet activation and platelet aggregation are increased in NASH but not in steatosis or insulin resistance. Antiplatelet therapy (APT; aspirin/clopidogrel, ticagrelor) but not nonsteroidal anti-inflammatory drug (NSAID) treatment with sulindac prevented NASH and subsequent HCC development. Intravital microscopy showed that liver colonization by platelets depended primarily on Kupffer cells at early and late stages of NASH, involving hyaluronan-CD44 binding. APT reduced intrahepatic platelet accumulation and the frequency of platelet-immune cell interaction, thereby limiting hepatic immune cell trafficking. Consequently, intrahepatic cytokine and chemokine release, macrovesicular steatosis and liver damage were attenuated. Platelet cargo, platelet adhesion and platelet activation but not platelet aggregation were identified as pivotal for NASH and subsequent hepatocarcinogenesis. In particular, platelet-derived GPIbα proved critical for development of NASH and subsequent HCC, independent of its reported cognate ligands vWF, P-selectin or Mac-1, offering a potential target against NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Furthermore, we show that the absence of B cells prevented HCC development.”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [20]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment of cardiometabolic comorbidities may modify disease progression and contribute to a reduction in liverrelated events ( e.g. statins, aspirin, renin-angiotensinaldosterone modulators). 273,274”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [273]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hepatic deregulation of several lipid and cholesterol metabolism genes, usually found in NASH livers,3,20,29 was prevented in JH-/- CD-HFD mice (Fig. S1R).”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [20]
In the citing paper
“Moreover, platelets are a rich source of growth factors, including PDGF, and thereby promote proliferation of PDGFR-expressing cells such as HSCs in non-NASH settings.99”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [99]
In the citing paper
“In addition, sterile inflammation, mediated by damage-associated molecular patterns and metabolite-associated molecular patterns,19,20 is considered an important driver of liver injury in NASH.”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [20]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
(2008) · Journal of Machine Learning Research · Cited by 33,051
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q., Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw377 · Cited by 10,799
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110
Research works printed but not linked: 1
- European Commission. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Med Etika Bioet. 9, 12–19 (2002).
Cited by
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Self-citationTacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Self-citationMechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Immunotherapies for hepatocellular carcinoma
Llovet, J. M., Castet, F., Heikenwalder, M., Maini, M. K., Mazzaferro, V., Pinato, D. J., Pikarsky, E., Zhu, A. X., & Finn, R. S. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00573-2 · Cited by 1,843
Self-citationNASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294
Self-citation
Metadata
- Authors
- Malehmir, M., Pfister, D., Gallage, S., Szydlowska, M., Inverso, D., Kotsiliti, E., Leone, V., Peiseler, M., Surewaard, B. G. J., Rath, D., Ali, A., Wolf, M. J., Drescher, H., Healy, M. E., Dauch, D., Kroy, D., Krenkel, O., Kohlhepp, M., Engleitner, T., Olkus, A., Sijmonsma, T., Volz, J., Deppermann, C., Stegner, D., Helbling, P., Nombela-Arrieta, C., Rafiei, A., Hinterleitner, M., Rall, M., Baku, F., Borst, O., Wilson, C. L., Leslie, J., O’Connor, T., Weston, C. J., Chauhan, A., Adams, D. H., Sheriff, L., Teijeiro, A., Prinz, M., Bogeska, R., Anstee, N., Bongers, M. N., Notohamiprodjo, M., Geisler, T., Withers, D. J., Ware, J., Mann, D. A., Augustin, H. G., Vegiopoulos, A., Milsom, M. D., Rose, A. J., Lalor, P. F., Llovet, J. M., Pinyol, R., Tacke, F., Rad, R., Matter, M., Djouder, N., Kubes, P., Knolle, P. A., Unger, K., Zender, L., Nieswandt, B., Gawaz, M., Weber, A., & Heikenwalder, M.
- Affiliations
- University of Zurich (CH)
- German Cancer Research Center (DE)
- University of Calgary (CA)
- University of Tübingen (DE)
- Universitätsklinikum Aachen (DE)
- Universitätsklinikum Tübingen (DE)
- University of Würzburg (DE)
- Newcastle University (GB)
- Helmholtz Munich (DE)
- National Institute for Health and Care Research (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Birmingham (GB)
- Spanish National Cancer Research Centre (ES)
- University of Freiburg (DE)
- MRC London Institute of Medical Sciences (GB)
- University of Arkansas for Medical Sciences (US)
- Monash University (AU)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Hospital Clínic de Barcelona (ES)
- University Hospital of Basel (CH)
- Technical University of Munich (DE)
- Corresponding author
- Weber, Achim
- ORCID
- Malehmir, Mohsen
- Pfister, Dominik
- Gallage, Suchira
- Szydlowska, Marta
- Inverso, Donato
- Kotsiliti, Elena
- Peiseler, Moritz
- Surewaard, Bas G. J.
- Rath, Dominik
- Ali, Adnan
- Drescher, Hannah
- Healy, Marc E.
- Dauch, Daniel
- Kroy, Daniela
- Krenkel, Oliver
- Kohlhepp, Marlene
- Engleitner, Thomas
- Olkus, Alexander
- Sijmonsma, Tjeerd
- Deppermann, Carsten
- Stegner, David
- Helbling, Patrick
- Nombela-Arrieta, César
- Hinterleitner, Martina
- Borst, Oliver
- Wilson, Caroline L.
- Leslie, Jack
- Weston, Christopher J.
- Chauhan, Abhishek
- Adams, David H.
- Sheriff, Lozan
- Teijeiro, Ana
- Prinz, Marco
- Bogeska, Ruzhica
- Anstee, Natasha
- Bongers, Malte N.
- Notohamiprodjo, Mike
- Geisler, Tobias
- Withers, Dominic J.
- Ware, Jerry
- Mann, Derek A.
- Augustin, Hellmut G.
- Vegiopoulos, Alexandros
- Milsom, Michael D.
- Rose, Adam J.
- Lalor, Patricia F.
- Llovet, Josep M.
- Pinyol, Roser
- Tacke, Frank
- Rad, Roland
- Matter, Matthias
- Djouder, Nabil
- Kubes, Paul
- Knolle, Percy A.
- Unger, Kristian
- Zender, Lars
- Nieswandt, Bernhard
- Gawaz, Meinrad
- Weber, Achim
- Heikenwalder, Mathias
- Venue
- Nature Medicine
- Published
- 2019-04
- Volume
- 25
- Issue
- 4
- Pages
- 641-655
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC12452109
- OpenAlex
- W2934212324
- Cited by
- 398
- References
- 92
- Citations by year
- 2026: 48 · 2025: 51 · 2024: 55 · 2023: 57 · 2022: 73 · 2021: 55 · 2020: 41 · 2019: 17
- FWCI
- 35.40
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-02-18)
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by)
- mediaTUM (Technical University of Munich) (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Wellcome Trust (098565/Z/12/Z)
- Cancer Research UK (26813, 23390)
- National Institute for Health and Care Research (NF-SI-0512-10080, NF-SI-0616-10012)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (182764, 320030)
- Medical Research Council (MR/M009157/1, MR/K001949/1, MC_PC_14123)
- National Cancer Institute (P30CA196521)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- nonalcoholic steatohepatitis, hepatocellular carcinoma, platelet activation, platelet aggregation, antiplatelet therapy, Kupffer cells, macrovesicular steatosis, hepatocarcinogenesis, platelet adhesion, non-alcoholic fatty liver disease
- MeSH terms
- Animals, Blood Platelets, Body Weight, Cytoplasmic Granules, Endothelium, Humans, Hyaluronic Acid, Kupffer Cells, Liver, Liver Neoplasms, Mice, Transgenic, Platelet Aggregation, Platelet Aggregation Inhibitors, Platelet Count, Cytokines, Hyaluronan Receptors, Platelet Glycoprotein GPIb-IX Complex, Hepatocytes, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. https://app.cochat.ai/papers/10.1038/s41591-019-0379-5
- The paper
- Malehmir, M., Pfister, D., Gallage, S., Szydlowska, M., Inverso, D., Kotsiliti, E., Leone, V., Peiseler, M., Surewaard, B. G. J., Rath, D., Ali, A., Wolf, M. J., Drescher, H., Healy, M. E., Dauch, D., Kroy, D., Krenkel, O., Kohlhepp, M., Engleitner, T., . . . Heikenwalder, M. (2019). Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. Nature Medicine. https://doi.org/10.1038/s41591-019-0379-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.